Parse Biosciences
Parse Biosciences is a biotechnology startup company that develops single-cell sequencing kit solutions for researchers.
About Parse Biosciences
Parse Bio is a biotechnology startup company developing single-cell sequencing kit solutions for researchers. By using combinatorial cDNA barcoding within cells themselves, Parse Biosciences’s technology allows researchers to eliminate the need for complex and expensive microfluidic instruments. Additionally, the company’s technology enables samples to be fixed, frozen, and stored, allowing researchers to separate out the sample extraction from downstream library preparation steps. This capability empowers researchers to run fixed samples collected on different dates together in a single experiment, providing greater control over sample handling and reducing handling errors. Split Biosciences rebranded as Parse Biosciences in 2020. The Seattle, Washington-based biotech company was established in 2018 by Alex Rosenberg, Charlie Roco, and Georg Friedrich Seelig.
Company Facts
- Headquarters
- Seattle
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- private
- Employees
- c_00101_00250
- Funding Stage
- m_and_a
- Total Funding
- $99,962,500
- Last Funding Type
- series_c
- Last Funding Date
- 2023-12-14
- Website
- parsebiosciences.com
Industries & Categories
Bioinformatics, Biotechnology, Genetics, Life Science
Social Links
Canonical: https://fsome.com/organization/parse-biosciences-23520 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.